2020 annual financial data
Viridian Therapeutics 2020 Operating margin
Direct answer
Operating margin was -10,512.38%.
Operating income was -110,380,000 USD and net income was -110,715,000 USD.
Operating cash flow was -29,779,000 USD.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,050,000 USD
- Operating income
- -110,380,000 USD
- Net income
- -110,715,000 USD
- Operating cash flow
- -29,779,000 USD